T. Arledge
Impact in
- Rheumatology top 2%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Spondyloarthritis Studies and Treatments 7
- Rheumatoid Arthritis Research and Therapies 5
- Systemic Lupus Erythematosus Research 2
-
- Psoriasis: Treatment and Pathogenesis 3
- Co-authors
- Bengt Hoepken (8 shared papers)C. Stach (7 shared papers)Danuta Kielar (7 shared papers)Philip J. Mease (5 shared papers)Roy Fleischmann (4 shared papers)Franz Woltering (5 shared papers)J. Wollenhaupt (3 shared papers)Atul Deodhar (3 shared papers)
- Journals
- Annals of the Rheumatic Diseases (6 papers)Journal of Allergy and Clinical Immunology (1 paper)Lara D. Veeken (1 paper)Clinical and Experimental Rheumatology (1 paper)Data Archiving and Networked Services (DANS) (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
T. Arledge
10 papers receiving 464 citations
T. Arledge's Hit Papers
Peers
Comparison fields: 5 of 35
- Rheumatology 365
- Hematology 119
- Immunology 222
- Dermatology 35
- Complementary and Manual Therapy 3
Countries citing papers authored by T. Arledge
This map shows the geographic impact of T. Arledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Arledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Arledge more than expected).
Fields of papers citing papers by T. Arledge
This network shows the impact of papers produced by T. Arledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Arledge. The network helps show where T. Arledge may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Arledge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA) Hit paper breakdown → | 2013 | 372 |
| 2 | 2013 | 61 | |
| 3 | 1996 | 16 | |
| 4 | Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis : 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study | 2012 | 10 |
| 5 | 2012 | 5 | |
| 6 | EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE : 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY | 2013 | 4 |
| 7 | 2013 | 4 | |
| 8 | 2013 | 3 | |
| 9 | LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL | 2014 | 1 |
| 10 | 2015 | 1 |
About T. Arledge
T. Arledge is a scholar working on Rheumatology, Immunology, Hematology, Neurology and Behavioral Neuroscience, having authored 10 papers that have together received 477 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Systemic Lupus Erythematosus Research (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Peripheral Neuropathies and Disorders (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Asthma and respiratory diseases (1 paper). The work is most often cited by research in Rheumatology (365 citations), Hematology (119 citations), Immunology (222 citations), Dermatology (35 citations) and Complementary and Manual Therapy (3 citations). T. Arledge has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Bengt Hoepken, C. Stach, Danuta Kielar, Philip J. Mease, Roy Fleischmann, Franz Woltering, J. Wollenhaupt, Atul Deodhar, Désirée van der Heijde and Majed Khraishi. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of Allergy and Clinical Immunology, Lara D. Veeken, Clinical and Experimental Rheumatology and Data Archiving and Networked Services (DANS).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.